BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

823 related articles for article (PubMed ID: 27199064)

  • 1. Statin-Associated Side Effects.
    Thompson PD; Panza G; Zaleski A; Taylor B
    J Am Coll Cardiol; 2016 May; 67(20):2395-2410. PubMed ID: 27199064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statin-induced necrotizing autoimmune myopathy (SINAM): case report and review of the literature.
    Cornelis L; Duyck J; Dedeurwaerdere F; De Schoenmakere G; Malfait T
    Acta Clin Belg; 2023 Aug; 78(4):336-341. PubMed ID: 36511106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statin-associated autoimmune myopathy and anti-HMGCR autoantibodies.
    Mohassel P; Mammen AL
    Muscle Nerve; 2013 Oct; 48(4):477-83. PubMed ID: 23519993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statins, myalgia, and rhabdomyolysis.
    Tournadre A
    Joint Bone Spine; 2020 Jan; 87(1):37-42. PubMed ID: 30735805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotype standardization for statin-induced myotoxicity.
    Alfirevic A; Neely D; Armitage J; Chinoy H; Cooper RG; Laaksonen R; Carr DF; Bloch KM; Fahy J; Hanson A; Yue QY; Wadelius M; Maitland-van Der Zee AH; Voora D; Psaty BM; Palmer CN; Pirmohamed M
    Clin Pharmacol Ther; 2014 Oct; 96(4):470-6. PubMed ID: 24897241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statin induced necrotizing autoimmune myopathy.
    Babu S; Li Y
    J Neurol Sci; 2015 Apr; 351(1-2):13-17. PubMed ID: 25765229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune-mediated statin myopathy.
    Loganathan P; Oddis CV; Aggarwal R
    Expert Rev Clin Immunol; 2016; 12(1):33-8. PubMed ID: 26515829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statin-associated myopathy.
    Thompson PD; Clarkson P; Karas RH
    JAMA; 2003 Apr; 289(13):1681-90. PubMed ID: 12672737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Necrotizing Autoimmune myopathy: A case report on statin induced rhabdomyolysis requiring immunosuppressive therapy.
    Kunwar S; Parekh JD; Chilukuri RS; Andukuri VA
    Drug Discov Ther; 2018; 12(5):315-317. PubMed ID: 30464165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severity of statin-induced adverse effects on muscle and associated conditions: data from the DAMA study.
    Pedro-Botet J; Millán Núñez-Cortés J; Chillarón JJ; Flores-Le Roux JA; Rius J
    Expert Opin Drug Saf; 2016 Dec; 15(12):1583-1587. PubMed ID: 27645494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk identification and possible countermeasures for muscle adverse effects during statin therapy.
    Magni P; Macchi C; Morlotti B; Sirtori CR; Ruscica M
    Eur J Intern Med; 2015 Mar; 26(2):82-8. PubMed ID: 25640999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Statin-associated muscle symptoms : Current management in 2018].
    Kosinski C; Tran C; Kuntzer T; Rodondi N; Collet TH
    Rev Med Suisse; 2018 Feb; 14(596):462-469. PubMed ID: 29489126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statins and myotoxicity: a therapeutic limitation.
    Tiwari A; Bansal V; Chugh A; Mookhtiar K
    Expert Opin Drug Saf; 2006 Sep; 5(5):651-66. PubMed ID: 16907655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statin-fibrate combination therapy.
    Shek A; Ferrill MJ
    Ann Pharmacother; 2001; 35(7-8):908-17. PubMed ID: 11485144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suggested clinical approach for the diagnosis and management of 'statin intolerance' with an emphasis on muscle-related side-effects.
    Sivashanmugarajah A; Fulcher J; Sullivan D; Elam M; Jenkins A; Keech A
    Intern Med J; 2019 Sep; 49(9):1081-1091. PubMed ID: 31507054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statin induced myotoxicity.
    Sathasivam S
    Eur J Intern Med; 2012 Jun; 23(4):317-24. PubMed ID: 22560377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The broad spectrum of statin myopathy: from myalgia to rhabdomyolysis.
    Harper CR; Jacobson TA
    Curr Opin Lipidol; 2007 Aug; 18(4):401-8. PubMed ID: 17620856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immune-mediated necrotizing myopathy associated with antibodies to hydroxy-methyl-glutaryl-coenzyme A reductase].
    Hinschberger O; Lohmann C; Lannes B; Martzolff L; Vo BD; Jaeger-Bizet F; Ciobanu E; Kieffer P
    Rev Med Interne; 2014 Aug; 35(8):546-9. PubMed ID: 23910221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of HMG-CoA reductase inhibitors on skeletal muscle: are all statins the same?
    Evans M; Rees A
    Drug Saf; 2002; 25(9):649-63. PubMed ID: 12137559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Muscle-related adverse effects of statins].
    Pohjola-Sintonen S; Julkunen H
    Duodecim; 2014; 130(16):1622-7. PubMed ID: 25269368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.